Possible interaction between cisapride and bromperidolISHIDA, M; OTANI, K; YASUI, N et al.Progress in neuro-psychopharmacology & biological psychiatry. 1997, Vol 21, Num 1, pp 235-238, issn 0278-5846Article

TOXIKOLOGISCHE, ENDOKRINOLOGISCHE UND KLINISCHE ASPEKTE BEI DER PRUEFUNG EINES NEUEN NEUROLEPTIKUMS (BROMPERIDOL): WISSENSCHAFTLICHES GESFNAECH ANLAESSLICH DES SYMPOSIUMS UEBER BROMPERIDOL, ZUERICH, 26-27 NOVEMBER 1976 = ASPECTS TOXICOLOGIQUES, ENDOCRINOLOGIQUES, ET CLINIQUES LORS DE L'ESSAI D'UN NOUVEAU NEUROLEPTIQUE: BROMPERIDOL. PRESENTATION DU SYMPOSIUM SUR LE BROMPERIDOL: ZUERICH 26-27 NOVEMBRE 19761978; INTERNATION. PHARMACOPSYCHIATRY; CHE; DA. 1978; VOL. 13; SUPPL. 1; 94 P.; BIBL. DISSEM.Article

Correlation between steady-state plasma concentrations (Css) of bromperidol and haloperidolYASUI, N; OTANI, K; KONDO, T et al.Progress in neuro-psychopharmacology & biological psychiatry. 1998, Vol 22, Num 3, pp 485-492, issn 0278-5846Article

Effects of various factors including the CYP2D6 genotype and coadministration of flunitrazepam on the steady-state plasma concentrations of bromperidol and its reduced metaboliteSUZUKI, A; OTANI, K; MIHARA, K et al.Psychopharmacologia. 1998, Vol 135, Num 4, pp 333-337, issn 0033-3158Article

Relationship between Taq1 A dopamine D2 receptor (DRD2) polymorphism and prolactin response to bromperidolMIHARA, Kazuo; SUZUKI, Akihito; KONDO, Tsuyoshi et al.American journal of medical genetics. 2001, Vol 105, Num 3, pp 271-274, issn 0148-7299Conference Paper

No Pharmacokinetic but pharmacodynamic interactions between cisapride and bromperidol or haloperidolMIHARA, K; OTANI, K; YASUI, N et al.Therapeutic drug monitoring. 1999, Vol 21, Num 3, pp 297-300, issn 0163-4356Article

Poor reliability of therapeutic drug monitoring data for haloperidol and bromperidol using enzyme immunoassayYASUI-FURUKORI, Norio; FURUKORI, Hanako; SAITO, Manabu et al.Therapeutic drug monitoring. 2003, Vol 25, Num 6, pp 709-714, issn 0163-4356, 6 p.Article

Involvement of CYP3A4 in the metabolism of bromperidol in vitroSATO, S; SOMEYA, T; SHIOIRI, T et al.Pharmacology & toxicology. 2000, Vol 86, Num 3, pp 145-148, issn 0901-9928Article

Therapeutic effects of bromperidol on the five dimensions of schizophrenic symptomsYASUI-FURUKORI, Norio; KONDO, Tsuyoshi; ISHIDA, Masayuki et al.Progress in neuro-psychopharmacology & biological psychiatry. 2002, Vol 26, Num 1, pp 53-57, issn 0278-5846Article

BROMPERIDOL MAINTENANCE IN SCHIZOPHRENIAMCEVOY JP; WILSON WH; BAN TA et al.1982; PHARMACOPSYCHIATRIA; ISSN 0720-4280; DEU; DA. 1982; VOL. 15; NO 3; PP. 95-96; ABS. GER; BIBL. 6 REF.Article

Comparison of the anti-dopamine D₂ and anti-serotonin 5-HT_2A activities of chlorpromazine, bromperidol, haloperidol and second-generation antipsychotics parent compounds and metabolites thereofSUZUKI, Hidenobu; GEN, Keishi; INOUE, Yuichi et al.Journal of psychopharmacology (Oxford). 2013, Vol 27, Num 4, pp 396-400, issn 0269-8811, 5 p.Article

Simultaneous determination of four basic metabolites formed from butyrophenone type agents by HPLC with dual ultraviolet detectionHIGASHI, Yasuhiko; SAKATA, Masatoshi; FUJII, Youichi et al.Journal of liquid chromatography & related technologies. 2006, Vol 29, Num 17-20, pp 2853-2862, issn 1082-6076, 10 p.Article

No relationship between - 141C Ins/Del polymorphism in the promoter region of dopamine D2 receptor and extrapyramidal adverse effects of selective dopamine D2 antagonists in schizophrenic patients: a preliminary studyMIHARA, Kazuo; KONDO, Tsuyoshi; SUZUKI, Akihito et al.Psychiatry research. 2001, Vol 101, Num 1, pp 33-38, issn 0165-1781Article

Interindividual variation in bromperidol metabolism and relationship to therapeutic effectsSOMEYA, T; MURATAKE, T; HIROKANE, G et al.Journal of clinical psychopharmacology. 2000, Vol 20, Num 2, pp 175-180, issn 0271-0749Article

The characteristics of side-effects of bromperidol in schizophrenic patientsYASUI-FURUKORI, Norio; KONDO, Tsuyoshi; ISHIDA, Masayuki et al.Psychiatry and clinical neurosciences (Carlton. Print). 2002, Vol 56, Num 1, pp 103-106, issn 1323-1316Article

Simultaneous determination of haloperidol and bromperidol and their reduced metabolites by liquid-liquid extraction and automated column-switching high-performance liquid chromatographyYASUI-FUMKORI, Norio; INOUE, Yoshimasa; CHIBA, Misturu et al.Journal of chromatography. B. 2004, Vol 805, Num 1, pp 175-180, issn 1570-0232, 6 p.Article

No effect of the anticholinergic drugs trihexyphenidyl and biperiden on the plasma concentrations of bromperidol and its reduced metaboliteOTANI, K; ISHIDA, M; YASUI, N et al.Therapeutic drug monitoring. 1997, Vol 19, Num 2, pp 165-168, issn 0163-4356Article

Conversion of bromperidol to reduced bromperidol in human liverSOMEYA, T; INABA, T; TYNDALE, R. F et al.Neuropsychopharmacology (New York, NY). 1991, Vol 5, Num 3, pp 177-182, issn 0893-133XArticle

Clinical efficacy, extrapyramidal symptoms and serum levels: influence of administration schedules and concomitant drugs on serum bromperidol concentrationsFUJII, Y; TATEYAMA, M; KAMISADA, M et al.Folia Psychiatrica et Neurologica Japonica. 1984, Vol 38, Num 2, pp 121-136, issn 0015-5721Article

DOUBLE-BLIND COMPARISON OF BROMPERIDOL AND PERPHENAZINEWOGGON B; ANGST J.1978; INTERNATION. PHARMACOPSYCHIATRY; CHE; DA. 1978; VOL. 13; NO 3; PP. 165-176; BIBL. 10 REF.Article

SEPARATION AND QUANTITATION OF BROMPERIDOL IN PHARMACEUTICAL PREPARATIONS BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY AND HIGH-PERFORMANCE THIN-LAYER CHROMATOGRAPHYVAN DEN EECKHOUT E; BENS GA; DE MOERLOOSE P et al.1980; J. CHROMATOGR.; NLD; DA. 1980; VOL. 193; NO 2; PP. 255-263; BIBL. 11 REF.Article

Tératogénicité du bromperidol chez le ratIMAI, S; TAUCHI, K; KUEN-JENG HUANG et al.Journal of toxicological sciences. 1984, Vol 9, pp 109-126, issn 0388-1350, suppl. 1Article

Bromperidol radioimmunoassay: human plasma levelsTISCHIO, J; HETYEI, N; PATRICK, J et al.Journal of pharmaceutical sciences. 1984, Vol 73, Num 4, pp 546-548, issn 0022-3549Article

Biotransformation of bromperidol in rat, dog, and manWONG, F. A; BATEMAN, C. P; SHAW, C. J et al.Drug metabolism and disposition. 1983, Vol 11, Num 4, pp 301-307, issn 0090-9556Article

TISSUE DISTRIBUTION STUDIES OF (¹⁸F) HALOPERIDOL, (¹⁸F)-BETA -(4-FLUOROBENZOYL) PROPIONIC ACID AND (⁸²BR) BROMPERIDOL BY EXTERNAL SCINTIGRAPHYDIGENIS GA; VINCENT SH; KOOK CS et al.1981; J. PHARM. SCI.; ISSN 0022-3549; USA; DA. 1981; VOL. 70; NO 9; PP. 985-989; BIBL. 18 REF.Article